The Market Reports

Index

1 Montelukast Intermediate Market Overview
1.1 Product Overview and Scope of Montelukast Intermediate
1.2 Montelukast Intermediate Segment by Type
1.2.1 Global Montelukast Intermediate Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 GMP
1.2.3 Non-GMP
1.3 Montelukast Intermediate Segment by Application
1.3.1 Global Montelukast Intermediate Sales Comparison by Application: (2021-2027)
1.3.2 Asthma
1.3.3 Allergic Rhinitis
1.3.4 Bronchospasm
1.3.5 Urticaria
1.4 Global Montelukast Intermediate Market Size Estimates and Forecasts
1.4.1 Global Montelukast Intermediate Revenue 2016-2027
1.4.2 Global Montelukast Intermediate Sales 2016-2027
1.4.3 Montelukast Intermediate Market Size by Region: 2016 Versus 2021 Versus 2027

2 Montelukast Intermediate Market Competition by Manufacturers
2.1 Global Montelukast Intermediate Sales Market Share by Manufacturers (2016-2021)
2.2 Global Montelukast Intermediate Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Montelukast Intermediate Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Montelukast Intermediate Manufacturing Sites, Area Served, Product Type
2.5 Montelukast Intermediate Market Competitive Situation and Trends
2.5.1 Montelukast Intermediate Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Montelukast Intermediate Players Market Share by Revenue
2.5.3 Global Montelukast Intermediate Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Montelukast Intermediate Retrospective Market Scenario by Region
3.1 Global Montelukast Intermediate Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Montelukast Intermediate Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Montelukast Intermediate Market Facts & Figures by Country
3.3.1 North America Montelukast Intermediate Sales by Country
3.3.2 North America Montelukast Intermediate Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Montelukast Intermediate Market Facts & Figures by Country
3.4.1 Europe Montelukast Intermediate Sales by Country
3.4.2 Europe Montelukast Intermediate Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Montelukast Intermediate Market Facts & Figures by Region
3.5.1 Asia Pacific Montelukast Intermediate Sales by Region
3.5.2 Asia Pacific Montelukast Intermediate Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Montelukast Intermediate Market Facts & Figures by Country
3.6.1 Latin America Montelukast Intermediate Sales by Country
3.6.2 Latin America Montelukast Intermediate Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Montelukast Intermediate Market Facts & Figures by Country
3.7.1 Middle East and Africa Montelukast Intermediate Sales by Country
3.7.2 Middle East and Africa Montelukast Intermediate Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Montelukast Intermediate Historic Market Analysis by Type
4.1 Global Montelukast Intermediate Sales Market Share by Type (2016-2021)
4.2 Global Montelukast Intermediate Revenue Market Share by Type (2016-2021)
4.3 Global Montelukast Intermediate Price by Type (2016-2021)

5 Global Montelukast Intermediate Historic Market Analysis by Application
5.1 Global Montelukast Intermediate Sales Market Share by Application (2016-2021)
5.2 Global Montelukast Intermediate Revenue Market Share by Application (2016-2021)
5.3 Global Montelukast Intermediate Price by Application (2016-2021)

6 Key Companies Profiled
6.1 VIVAN Life Sciences
6.1.1 VIVAN Life Sciences Corporation Information
6.1.2 VIVAN Life Sciences Description and Business Overview
6.1.3 VIVAN Life Sciences Montelukast Intermediate Sales, Revenue and Gross Margin (2016-2021)
6.1.4 VIVAN Life Sciences Montelukast Intermediate Product Portfolio
6.1.5 VIVAN Life Sciences Recent Developments/Updates
6.2 P.G. Shah & Co.
6.2.1 P.G. Shah & Co. Corporation Information
6.2.2 P.G. Shah & Co. Description and Business Overview
6.2.3 P.G. Shah & Co. Montelukast Intermediate Sales, Revenue and Gross Margin (2016-2021)
6.2.4 P.G. Shah & Co. Montelukast Intermediate Product Portfolio
6.2.5 P.G. Shah & Co. Recent Developments/Updates
6.3 Manus Aktteva Biopharma
6.3.1 Manus Aktteva Biopharma Corporation Information
6.3.2 Manus Aktteva Biopharma Description and Business Overview
6.3.3 Manus Aktteva Biopharma Montelukast Intermediate Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Manus Aktteva Biopharma Montelukast Intermediate Product Portfolio
6.3.5 Manus Aktteva Biopharma Recent Developments/Updates
6.4 Ortin Laboratories
6.4.1 Ortin Laboratories Corporation Information
6.4.2 Ortin Laboratories Description and Business Overview
6.4.3 Ortin Laboratories Montelukast Intermediate Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Ortin Laboratories Montelukast Intermediate Product Portfolio
6.4.5 Ortin Laboratories Recent Developments/Updates

7 Montelukast Intermediate Manufacturing Cost Analysis
7.1 Montelukast Intermediate Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Montelukast Intermediate
7.4 Montelukast Intermediate Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Montelukast Intermediate Distributors List
8.3 Montelukast Intermediate Customers

9 Montelukast Intermediate Market Dynamics
9.1 Montelukast Intermediate Industry Trends
9.2 Montelukast Intermediate Growth Drivers
9.3 Montelukast Intermediate Market Challenges
9.4 Montelukast Intermediate Market Restraints

10 Global Market Forecast
10.1 Montelukast Intermediate Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Montelukast Intermediate by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Montelukast Intermediate by Type (2022-2027)
10.2 Montelukast Intermediate Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Montelukast Intermediate by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Montelukast Intermediate by Application (2022-2027)
10.3 Montelukast Intermediate Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Montelukast Intermediate by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Montelukast Intermediate by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Montelukast Intermediate Sales (MT) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Montelukast Intermediate Sales (MT) Comparison by Application (2021-2027)
Table 3. Global Montelukast Intermediate Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Montelukast Intermediate Covered in This Study
Table 5. Global Montelukast Intermediate Sales (MT) of Key Manufacturers (2016-2021)
Table 6. Global Montelukast Intermediate Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Montelukast Intermediate Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Montelukast Intermediate Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Montelukast Intermediate Average Price (USD/MT) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Montelukast Intermediate Manufacturing Sites and Area Served
Table 11. Manufacturers Montelukast Intermediate Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Montelukast Intermediate by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Montelukast Intermediate as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Montelukast Intermediate Sales by Region (2016-2021) & (MT)
Table 16. Global Montelukast Intermediate Sales Market Share by Region (2016-2021)
Table 17. Global Montelukast Intermediate Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Montelukast Intermediate Sales by Country (2016-2021) & (MT)
Table 19. North America Montelukast Intermediate Sales Market Share by Country (2016-2021)
Table 20. North America Montelukast Intermediate Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Montelukast Intermediate Revenue Market Share by Country (2016-2021)
Table 22. Europe Montelukast Intermediate Sales by Country (2016-2021) & (MT)
Table 23. Europe Montelukast Intermediate Sales Market Share by Country (2016-2021)
Table 24. Europe Montelukast Intermediate Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Montelukast Intermediate Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Montelukast Intermediate Sales by Region (2016-2021) & (MT)
Table 27. Asia Pacific Montelukast Intermediate Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Montelukast Intermediate Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Montelukast Intermediate Revenue Market Share by Region (2016-2021)
Table 30. Latin America Montelukast Intermediate Sales by Country (2016-2021) & (MT)
Table 31. Latin America Montelukast Intermediate Sales Market Share by Country (2016-2021)
Table 32. Latin America Montelukast Intermediate Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Montelukast Intermediate Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Montelukast Intermediate Sales by Country (2016-2021) & (MT)
Table 35. Middle East and Africa Montelukast Intermediate Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Montelukast Intermediate Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Montelukast Intermediate Revenue Market Share by Country (2016-2021)
Table 38. Global Montelukast Intermediate Sales (MT) by Type (2016-2021)
Table 39. Global Montelukast Intermediate Sales Market Share by Type (2016-2021)
Table 40. Global Montelukast Intermediate Revenue (Million US$) by Type (2016-2021)
Table 41. Global Montelukast Intermediate Revenue Share by Type (2016-2021)
Table 42. Global Montelukast Intermediate Price (USD/MT) by Type (2016-2021)
Table 43. Global Montelukast Intermediate Sales (MT) by Application (2016-2021)
Table 44. Global Montelukast Intermediate Sales Market Share by Application (2016-2021)
Table 45. Global Montelukast Intermediate Revenue (Million US$) by Application (2016-2021)
Table 46. Global Montelukast Intermediate Revenue Share by Application (2016-2021)
Table 47. Global Montelukast Intermediate Price (USD/MT) by Application (2016-2021)
Table 48. VIVAN Life Sciences Corporation Information
Table 49. VIVAN Life Sciences Description and Business Overview
Table 50. VIVAN Life Sciences Montelukast Intermediate Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 51. VIVAN Life Sciences Montelukast Intermediate Product
Table 52. VIVAN Life Sciences Recent Developments/Updates
Table 53. P.G. Shah & Co. Corporation Information
Table 54. P.G. Shah & Co. Description and Business Overview
Table 55. P.G. Shah & Co. Montelukast Intermediate Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 56. P.G. Shah & Co. Montelukast Intermediate Product
Table 57. P.G. Shah & Co. Recent Developments/Updates
Table 58. Manus Aktteva Biopharma Corporation Information
Table 59. Manus Aktteva Biopharma Description and Business Overview
Table 60. Manus Aktteva Biopharma Montelukast Intermediate Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 61. Manus Aktteva Biopharma Montelukast Intermediate Product
Table 62. Manus Aktteva Biopharma Recent Developments/Updates
Table 63. Ortin Laboratories Corporation Information
Table 64. Ortin Laboratories Description and Business Overview
Table 65. Ortin Laboratories Montelukast Intermediate Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 66. Ortin Laboratories Montelukast Intermediate Product
Table 67. Ortin Laboratories Recent Developments/Updates
Table 68. Production Base and Market Concentration Rate of Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Montelukast Intermediate Distributors List
Table 71. Montelukast Intermediate Customers List
Table 72. Montelukast Intermediate Market Trends
Table 73. Montelukast Intermediate Growth Drivers
Table 74. Montelukast Intermediate Market Challenges
Table 75. Montelukast Intermediate Market Restraints
Table 76. Global Montelukast Intermediate Sales Forecast by Type (2022-2027) & (MT)
Table 77. Global Montelukast Intermediate Sales Market Share Forecast by Type (2022-2027)
Table 78. Global Montelukast Intermediate Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 79. Global Montelukast Intermediate Revenue Market Share Forecast by Type (2022-2027)
Table 80. Global Montelukast Intermediate Sales Forecast by Application (2022-2027) & (MT)
Table 81. Global Montelukast Intermediate Sales Market Share Forecast by Application (2022-2027)
Table 82. Global Montelukast Intermediate Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 83. Global Montelukast Intermediate Revenue Market Share Forecast by Application (2022-2027)
Table 84. Global Montelukast Intermediate Sales Forecast by Region (2022-2027) & (MT)
Table 85. Global Montelukast Intermediate Sales Market Share Forecast by Region (2022-2027)
Table 86. Global Montelukast Intermediate Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 87. Global Montelukast Intermediate Revenue Market Share Forecast by Region (2022-2027)
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Montelukast Intermediate
Figure 2. Global Montelukast Intermediate Market Share by Type in 2020 & 2027
Figure 3. GMP Product Picture
Figure 4. Non-GMP Product Picture
Figure 5. Global Montelukast Intermediate Market Share by Application in 2020 & 2027
Figure 6. Asthma
Figure 7. Allergic Rhinitis
Figure 8. Bronchospasm
Figure 9. Urticaria
Figure 10. Global Montelukast Intermediate Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Montelukast Intermediate Market Size 2016-2027 (US$ Million)
Figure 12. Global Montelukast Intermediate Sales 2016-2027 (MT)
Figure 13. Global Montelukast Intermediate Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 14. Montelukast Intermediate Sales Share by Manufacturers in 2020
Figure 15. Global Montelukast Intermediate Revenue Share by Manufacturers in 2020
Figure 16. The Global 5 and 10 Largest Montelukast Intermediate Players: Market Share by Revenue in 2020
Figure 17. Montelukast Intermediate Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 18. Global Montelukast Intermediate Sales Market Share by Region (2016-2021)
Figure 19. Global Montelukast Intermediate Sales Market Share by Region in 2020
Figure 20. Global Montelukast Intermediate Revenue Market Share by Region (2016-2021)
Figure 21. Global Montelukast Intermediate Revenue Market Share by Region in 2020
Figure 22. U.S. Montelukast Intermediate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Canada Montelukast Intermediate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Germany Montelukast Intermediate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. France Montelukast Intermediate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. U.K. Montelukast Intermediate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Italy Montelukast Intermediate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Russia Montelukast Intermediate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. China Montelukast Intermediate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Japan Montelukast Intermediate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. South Korea Montelukast Intermediate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. India Montelukast Intermediate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Australia Montelukast Intermediate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Taiwan Montelukast Intermediate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Indonesia Montelukast Intermediate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Thailand Montelukast Intermediate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Malaysia Montelukast Intermediate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Philippines Montelukast Intermediate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Vietnam Montelukast Intermediate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Mexico Montelukast Intermediate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Brazil Montelukast Intermediate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Argentina Montelukast Intermediate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Turkey Montelukast Intermediate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Saudi Arabia Montelukast Intermediate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. U.A.E Montelukast Intermediate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Sales Market Share of Montelukast Intermediate by Type (2016-2021)
Figure 47. Sales Market Share of Montelukast Intermediate by Application (2016-2021)
Figure 48. Sales Market Share of Montelukast Intermediate by Application in 2020
Figure 49. Revenue Share of Montelukast Intermediate by Application (2016-2021)
Figure 50. Revenue Share of Montelukast Intermediate by Application in 2020
Figure 51. Manufacturing Cost Structure of Montelukast Intermediate
Figure 52. Manufacturing Process Analysis of Montelukast Intermediate
Figure 53. Montelukast Intermediate Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed